In vivo, human MSC-Exos significantly reduced the degree of myocardial necrosis, neutrophil infiltration and myocardial injury in rats with MI, promoted the proliferation of cardiomyocytes, upregulated miR-543 and inhibited COL4A1 (Yang et al., 2021). Here, COL4A1 is linked to myocardial infarction.